Tristel PLC
LSE: TSTL.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Matthew Giovanni Sassone
- Employees
- 233
- Headquarters
- Newmarket, United Kingdom
- IPO year
- 2005
- Market cap
- £195.3M
- Website
- https://www.tristel.com
Loading TSTL…
Loading profile data…Frequently asked questions about TSTL
What does Tristel PLC (TSTL.L) do?
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardi...
Where does TSTL.L trade?
Tristel PLC (TSTL.L) trades on the London Stock Exchange.
What sector is TSTL.L in?
Tristel PLC (TSTL.L) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of Tristel PLC?
Matthew Giovanni Sassone is the chief executive officer of Tristel PLC (TSTL.L).
Where is Tristel PLC headquartered?
Tristel PLC is headquartered in United Kingdom.
Does TSTL.L pay a dividend?
Yes — Tristel PLC (TSTL.L) paid a trailing twelve-month dividend of GBp 14.20 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did TSTL.L go public?
Tristel PLC (TSTL.L) completed its initial public offering in 2005.